Chids Mahadevan - May 10, 2021 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
Chief Accounting Officer
Signature
/s/ Shoshana Shendelman, Attorney-in-Fact
Stock symbol
APLT
Transactions as of
May 10, 2021
Transactions value $
$0
Form type
4
Date filed
5/14/2021, 08:08 PM
Next filing
Apr 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +8.54K $0.00 8.54K May 10, 2021 Direct F1
holding APLT Common Stock 25 May 10, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLT Stock Option (Right to Buy) Award $0 +13.4K $0.00 13.4K May 10, 2021 Common Stock 13.4K $17.05 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of Restricted Stock Units, representing a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the Restricted Stock Units were vested upon grant and one-fourth (1/4th) of the Restricted Stock Unites shall vest thereafter on each of May 10, 2022, May 10, 2023 and May 10, 2024,subject to the Reporting Person continuing to provide services through each such date.
F2 One-fourth (1/4th) of the shares subject to the Option were vested upon grant and the remainder of the shares subject to the Option shall vest thereafter in equal monthly installments over the three-year period following the date of grant, subject to the Reporting Person continuing to provide services through each such date.